Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathway

Shuying He1, Dafydd R Owen2, Scott A Jelinsky1

  • 1Inflammation and Immunology Research Unit, Pfizer Research, Cambridge, MA 02139.

Scientific Reports
|October 6, 2015
PubMed

Insights

Inhibiting SETD7 (SET domain containing lysine methyltransferase SETD7) reduces oxidative stress and inflammation by improving mitochondrial function. This suggests targeting SETD7 could treat diseases linked to reactive oxygen species (ROS) imbalance.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • Reactive oxygen species (ROS) homeostasis is critical for cellular function, and its imbalance, particularly accumulation, contributes to disease pathogenesis.
  • Lysine methylation, a post-translational modification, plays a role in cellular responses, but its specific involvement in ROS regulation is not fully understood.

Purpose of the Study:

  • To investigate the role of SET domain containing lysine methyltransferase SETD7 (SETD7) in regulating ROS-mediated signaling pathways.
  • To explore the therapeutic potential of targeting SETD7 in ROS-associated diseases.

Main Methods:

  • Utilized siRNA and a small molecule inhibitor to inhibit SETD7 activity in macrophages and Beas-2B cells.
  • Investigated the effects of SETD7 inhibition on NF-κB-induced oxidative stress, pro-inflammatory cytokine production, and mitochondrial antioxidant functions.
  • Examined the regulation of PPARGC1A and NFE2L2 by SETD7 and detected direct interaction between SETD7 and NFE2L2 using co-expression systems and purified proteins.

Main Results:

  • Inhibition of SETD7 effectively countered NF-κB-induced oxidative stress and pro-inflammatory cytokine production.
  • SETD7 inhibition enhanced mitochondrial antioxidant functions through negative regulation of PPARGC1A and NFE2L2.
  • Direct interaction between SETD7 and NFE2L2 was confirmed, indicating SETD7's role in the NFE2L2/ARE pathway.

Conclusions:

  • Lysine methylation by SETD7 is crucial for fine-tuning ROS signaling, impacting inflammatory responses and mitochondrial function.
  • Inhibition of SETD7 leads to the upregulation of antioxidant genes and improved ROS clearance.
  • Targeting SETD7 presents a potential therapeutic strategy for treating diseases associated with ROS imbalance.

Related Concept Videos

Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.5K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
Protein Modifications in the RER01:26

Protein Modifications in the RER

Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
7.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
27.2K